In vivo tissue response to resorbable silica xerogels as controlled-release materials

Shula Radin, Gehan El-Bassyouni, Edward Vresilovic, Evert Schepers, Paul Ducheyne

Research output: Contribution to journalArticle

189 Citations (Scopus)

Abstract

Biodegradable, controlled-release carrier materials with non-toxic degradation products are valuable for local delivery of biologically active molecules. Previously, it was shown that room-temperature processed silica sol-gels (or xerogels) are porous, resorbable materials that can release molecules of various sizes in a controlled, time dependent manner. Previous in vitro studies also demonstrated benefits of silica xerogels as controlled-release materials for the treatment of bone infections. Herein the tissue and cell response to xerogels is documented using a subacute implantation procedure. The tissue response was correlated to composition, surface properties, resorption rate and incorporation of the antibiotic vancomycin. Ca- and P-free and Ca- and P-containing xerogels, with and without apatite (AP) surface, were used. Xerogels were implanted either as discs in a subcutaneous site, or as granules in the iliac crest of New Zealand white rabbits. The samples with surrounding tissue were retrieved after 2 and 4 weeks of implantation. Silica xerogels implanted either as discs subcutaneously or as granules in the iliac crest showed a favorable tissue response. The granules, either with or without Ca and P content, gradually resorbed over time. The resorption was accompanied by extensive trabecular bone growth and a minimal inflammatory response. Ca- and P-containing granules with an AP-surface layer showed a slower resorption rate and more extensive new bone growth than those without AP layer. Among AP-coated granules, those with incorporated vancomycin showed the most favorable tissue response. The present in vivo data together with prior in vitro data suggest that these xerogels have potential as controlled-release materials for the treatment of bone infections and as carrier materials for a variety of other applications.

Original languageEnglish (US)
Pages (from-to)1043-1052
Number of pages10
JournalBiomaterials
Volume26
Issue number9
DOIs
StatePublished - Mar 1 2005

Fingerprint

Xerogels
Apatites
Silicon Dioxide
Silica
Tissue
Apatite
Bone
Bone Development
Vancomycin
Bone and Bones
Surface Properties
Silica Gel
Polymethyl Methacrylate
Infection
Molecules
Antibiotics
Anti-Bacterial Agents
Rabbits
Sol-gels
Surface properties

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Radin, S., El-Bassyouni, G., Vresilovic, E., Schepers, E., & Ducheyne, P. (2005). In vivo tissue response to resorbable silica xerogels as controlled-release materials. Biomaterials, 26(9), 1043-1052. https://doi.org/10.1016/j.biomaterials.2004.04.004
Radin, Shula ; El-Bassyouni, Gehan ; Vresilovic, Edward ; Schepers, Evert ; Ducheyne, Paul. / In vivo tissue response to resorbable silica xerogels as controlled-release materials. In: Biomaterials. 2005 ; Vol. 26, No. 9. pp. 1043-1052.
@article{9059d3f19de0498ebe70e481b3b52c9c,
title = "In vivo tissue response to resorbable silica xerogels as controlled-release materials",
abstract = "Biodegradable, controlled-release carrier materials with non-toxic degradation products are valuable for local delivery of biologically active molecules. Previously, it was shown that room-temperature processed silica sol-gels (or xerogels) are porous, resorbable materials that can release molecules of various sizes in a controlled, time dependent manner. Previous in vitro studies also demonstrated benefits of silica xerogels as controlled-release materials for the treatment of bone infections. Herein the tissue and cell response to xerogels is documented using a subacute implantation procedure. The tissue response was correlated to composition, surface properties, resorption rate and incorporation of the antibiotic vancomycin. Ca- and P-free and Ca- and P-containing xerogels, with and without apatite (AP) surface, were used. Xerogels were implanted either as discs in a subcutaneous site, or as granules in the iliac crest of New Zealand white rabbits. The samples with surrounding tissue were retrieved after 2 and 4 weeks of implantation. Silica xerogels implanted either as discs subcutaneously or as granules in the iliac crest showed a favorable tissue response. The granules, either with or without Ca and P content, gradually resorbed over time. The resorption was accompanied by extensive trabecular bone growth and a minimal inflammatory response. Ca- and P-containing granules with an AP-surface layer showed a slower resorption rate and more extensive new bone growth than those without AP layer. Among AP-coated granules, those with incorporated vancomycin showed the most favorable tissue response. The present in vivo data together with prior in vitro data suggest that these xerogels have potential as controlled-release materials for the treatment of bone infections and as carrier materials for a variety of other applications.",
author = "Shula Radin and Gehan El-Bassyouni and Edward Vresilovic and Evert Schepers and Paul Ducheyne",
year = "2005",
month = "3",
day = "1",
doi = "10.1016/j.biomaterials.2004.04.004",
language = "English (US)",
volume = "26",
pages = "1043--1052",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "9",

}

Radin, S, El-Bassyouni, G, Vresilovic, E, Schepers, E & Ducheyne, P 2005, 'In vivo tissue response to resorbable silica xerogels as controlled-release materials', Biomaterials, vol. 26, no. 9, pp. 1043-1052. https://doi.org/10.1016/j.biomaterials.2004.04.004

In vivo tissue response to resorbable silica xerogels as controlled-release materials. / Radin, Shula; El-Bassyouni, Gehan; Vresilovic, Edward; Schepers, Evert; Ducheyne, Paul.

In: Biomaterials, Vol. 26, No. 9, 01.03.2005, p. 1043-1052.

Research output: Contribution to journalArticle

TY - JOUR

T1 - In vivo tissue response to resorbable silica xerogels as controlled-release materials

AU - Radin, Shula

AU - El-Bassyouni, Gehan

AU - Vresilovic, Edward

AU - Schepers, Evert

AU - Ducheyne, Paul

PY - 2005/3/1

Y1 - 2005/3/1

N2 - Biodegradable, controlled-release carrier materials with non-toxic degradation products are valuable for local delivery of biologically active molecules. Previously, it was shown that room-temperature processed silica sol-gels (or xerogels) are porous, resorbable materials that can release molecules of various sizes in a controlled, time dependent manner. Previous in vitro studies also demonstrated benefits of silica xerogels as controlled-release materials for the treatment of bone infections. Herein the tissue and cell response to xerogels is documented using a subacute implantation procedure. The tissue response was correlated to composition, surface properties, resorption rate and incorporation of the antibiotic vancomycin. Ca- and P-free and Ca- and P-containing xerogels, with and without apatite (AP) surface, were used. Xerogels were implanted either as discs in a subcutaneous site, or as granules in the iliac crest of New Zealand white rabbits. The samples with surrounding tissue were retrieved after 2 and 4 weeks of implantation. Silica xerogels implanted either as discs subcutaneously or as granules in the iliac crest showed a favorable tissue response. The granules, either with or without Ca and P content, gradually resorbed over time. The resorption was accompanied by extensive trabecular bone growth and a minimal inflammatory response. Ca- and P-containing granules with an AP-surface layer showed a slower resorption rate and more extensive new bone growth than those without AP layer. Among AP-coated granules, those with incorporated vancomycin showed the most favorable tissue response. The present in vivo data together with prior in vitro data suggest that these xerogels have potential as controlled-release materials for the treatment of bone infections and as carrier materials for a variety of other applications.

AB - Biodegradable, controlled-release carrier materials with non-toxic degradation products are valuable for local delivery of biologically active molecules. Previously, it was shown that room-temperature processed silica sol-gels (or xerogels) are porous, resorbable materials that can release molecules of various sizes in a controlled, time dependent manner. Previous in vitro studies also demonstrated benefits of silica xerogels as controlled-release materials for the treatment of bone infections. Herein the tissue and cell response to xerogels is documented using a subacute implantation procedure. The tissue response was correlated to composition, surface properties, resorption rate and incorporation of the antibiotic vancomycin. Ca- and P-free and Ca- and P-containing xerogels, with and without apatite (AP) surface, were used. Xerogels were implanted either as discs in a subcutaneous site, or as granules in the iliac crest of New Zealand white rabbits. The samples with surrounding tissue were retrieved after 2 and 4 weeks of implantation. Silica xerogels implanted either as discs subcutaneously or as granules in the iliac crest showed a favorable tissue response. The granules, either with or without Ca and P content, gradually resorbed over time. The resorption was accompanied by extensive trabecular bone growth and a minimal inflammatory response. Ca- and P-containing granules with an AP-surface layer showed a slower resorption rate and more extensive new bone growth than those without AP layer. Among AP-coated granules, those with incorporated vancomycin showed the most favorable tissue response. The present in vivo data together with prior in vitro data suggest that these xerogels have potential as controlled-release materials for the treatment of bone infections and as carrier materials for a variety of other applications.

UR - http://www.scopus.com/inward/record.url?scp=4444263804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444263804&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2004.04.004

DO - 10.1016/j.biomaterials.2004.04.004

M3 - Article

C2 - 15369693

AN - SCOPUS:4444263804

VL - 26

SP - 1043

EP - 1052

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 9

ER -